Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;21(8):592-594.
doi: 10.2459/JCM.0000000000001013.

Left atrial appendage occlusion in patients with atrial fibrillation and a large prevalence of intracranial bleeding: a further confirmation

Patrizio Mazzone  1 , Paolo Della Bella, Andrea Radinovic
Affiliations
Editorial

Left atrial appendage occlusion in patients with atrial fibrillation and a large prevalence of intracranial bleeding: a further confirmation

Patrizio Mazzone et al. J Cardiovasc Med (Hagerstown). 2020 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019; 74:104–132.
    1. Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation 2012; 126:2381–2391.
    1. Cresti A, García-Fernández MA, Sievert H, et al. Prevalence of extra-appendage thrombosis in nonvalvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroIntervention 2019; 15:e225–e230.
    1. Holmes DR, Reddy VY, Turi ZG, et al. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised noninferiority trial. Lancet 2009; 374:534–542.
    1. Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014; 64:1–12.

MeSH terms

LinkOut - more resources